VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 40 filers reported holding VERONA PHARMA PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $138,000 | +23.2% | 13,446 | -50.6% | 0.07% | +35.2% |
| Q2 2022 | $112,000 | -37.4% | 27,196 | -23.7% | 0.05% | -18.2% |
| Q1 2022 | $179,000 | -21.8% | 35,656 | +4.5% | 0.07% | -14.3% |
| Q4 2021 | $229,000 | +26.5% | 34,106 | +2.9% | 0.08% | +16.7% |
| Q3 2021 | $181,000 | +74.0% | 33,156 | +113.8% | 0.07% | +61.0% |
| Q2 2021 | $104,000 | -11.9% | 15,506 | +10.0% | 0.04% | -18.0% |
| Q1 2021 | $118,000 | – | 14,102 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,111,112 | $11,356,000 | 29.98% |
| Aisling Capital Management LP | 1,332,485 | $13,618,000 | 9.04% |
| Abingworth LLP | 2,457,500 | $25,091,000 | 8.58% |
| Fairmount Funds Management LLC | 2,678,982 | $27,379,000 | 4.81% |
| Vivo Capital, LLC | 4,249,918 | $43,434,000 | 4.80% |
| NEA Management Company, LLC | 5,584,753 | $57,076,000 | 2.85% |
| Octagon Capital Advisors LP | 1,324,868 | $13,540,000 | 2.34% |
| Samsara BioCapital, LLC | 938,890 | $9,595,000 | 2.24% |
| ACT CAPITAL MANAGEMENT, LLC | 143,500 | $1,467,000 | 2.02% |
| Frazier Life Sciences Management, L.P. | 2,099,541 | $21,457,000 | 1.65% |